These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3683762)

  • 1. Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test.
    Cervo L; Samanin R
    Neuropharmacology; 1987 Oct; 26(10):1469-72. PubMed ID: 3683762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1990 Mar; 178(1):129-33. PubMed ID: 2158897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.
    Cervo L; Samanin R
    J Pharm Pharmacol; 1988 Feb; 40(2):155-6. PubMed ID: 2897457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraaccumbens dopaminergic lesion suppresses desipramine effects in the forced swim test but not in the neuronal activity of lateral septal nucleus.
    Gutiérrez-García AG; Contreras CM; Díaz-Meza JL; Bernal-Morales B; Rodríguez-Landa JF; Saavedra M
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):809-18. PubMed ID: 12921914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
    Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
    Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The nucleus accumbens: is it an exclusive component of the dopaminergic system of the basal ganglia?].
    Herrera-Marschitz M; Ungerstedt U
    Neurologia; 1987; 2(2):47-9. PubMed ID: 3274069
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation.
    Stamford JA; Kruk ZL; Millar J
    Brain Res; 1988 Jun; 454(1-2):282-8. PubMed ID: 3261616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional role of the nucleus accumbens in the control of the substantia nigra: electrophysiological investigations in intact and striatum-globus pallidus lesioned rats.
    Scarnati E; Campana E; Pacitti C
    Brain Res; 1983 Apr; 265(2):249-57. PubMed ID: 6850328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex.
    Phillips AG; Fibiger HC
    Can J Psychol; 1978 Jun; 32(2):58-66. PubMed ID: 737577
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation.
    Kurumiya S; Nakajima S
    Brain Res; 1988 May; 448(1):1-6. PubMed ID: 2968828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA-dopamine interaction in substantia nigra and nucleus accumbens--relevance to behavioral stimulation and stereotyped behavior.
    Scheel-Krüger J; Arnt J; Braestrup C; Christensen AV; Cools AR; Magelund G
    Adv Biochem Psychopharmacol; 1978; 19():343-6. PubMed ID: 567933
    [No Abstract]   [Full Text] [Related]  

  • 13. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    Midgley LP; Wagstaff JD; Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1994 Jan; 251(2-3):191-9. PubMed ID: 7908639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC; Verheijden PF; Leysen JE
    Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic mechanisms in the nucleus accumbens septi regulating rat motor activity: the effect of chronic treatment with desipramine.
    Płaznik A; Stefański R; Kostowski W
    Pharmacol Biochem Behav; 1990 Jul; 36(3):501-6. PubMed ID: 2165615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the nucleus accumbens and nigrostriatum in enkephalin-induced myoclonus.
    Dzoljic MR; van der Poel-Heisterkamp AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):103-6. PubMed ID: 6773072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat.
    Drago F; Caldwell JD; Pedersen CA; Continella G; Scapagnini U; Prange AJ
    Pharmacol Biochem Behav; 1986 May; 24(5):1185-8. PubMed ID: 3014562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesolimbic system, denervation and the climbing response in the mouse.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    Eur J Pharmacol; 1980 Aug; 66(2-3):207-15. PubMed ID: 6108225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.